Holger Weis

Holger Weis is a proven founder and senior executive with two decades of experience holding c-level positions at life science companies and is also a co-author of several scientific papers.

Mr. Weis is the Co-Founder, Chief Financial Officer and Director of biotech start-up company PhenoTarget Biosciences, Inc. and is also the founding principal of Weis Advisors, Inc., where he provides consulting services to life science companies. Mr. Weis’ impressive career has provided him with deep knowledge of the biotech industry and operational, financial, and strategic planning practices. Previously, Mr. Weis held numerous c-level leadership positions at life science companies like his 7-year tenure at DemeRx, Inc., a clinical stage pharmaceutical company where he served as Chief Operating Officer, Chief Financial Officer and President. From 2000-2011, Mr. Weis held leadership roles at medical technology and pharmaceutical companies, including as Chief Financial Officer & Treasurer of GMP Companies, Inc., which develops and commercializes pharmaceutical, medical device and diagnostic technologies. Earlier in his career, Mr. Weis served for 14 years at Ernst & Young, an internationally recognized professional services company. Mr. Weis has co-authored a number of scientific papers and presentations and is also an inventor on numerous patents and patent applications. Mr. Weis holds a Bachelor of Business Administration in Accounting from the University of Georgia and is a Certified Public Accountant.